000 | 01527 a2200385 4500 | ||
---|---|---|---|
005 | 20250513100452.0 | ||
264 | 0 | _c19961024 | |
008 | 199610s 0 0 eng d | ||
022 | _a0820-3946 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLiu, B A | |
245 | 0 | 0 |
_aHyponatremia and the syndrome of inappropriate secretion of antidiuretic hormone associated with the use of selective serotonin reuptake inhibitors: a review of spontaneous reports. _h[electronic resource] |
260 |
_bCMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne _cSep 1996 |
||
300 |
_a519-27 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
650 | 0 | 4 |
_a1-Naphthylamine _xadverse effects |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aFluoxetine _xadverse effects |
650 | 0 | 4 |
_aFluvoxamine _xadverse effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHyponatremia _xchemically induced |
650 | 0 | 4 |
_aInappropriate ADH Syndrome _xchemically induced |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aParoxetine _xadverse effects |
650 | 0 | 4 | _aProduct Surveillance, Postmarketing |
650 | 0 | 4 |
_aSelective Serotonin Reuptake Inhibitors _xadverse effects |
650 | 0 | 4 | _aSertraline |
700 | 1 | _aMittmann, N | |
700 | 1 | _aKnowles, S R | |
700 | 1 | _aShear, N H | |
773 | 0 |
_tCMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne _gvol. 155 _gno. 5 _gp. 519-27 |
|
999 |
_c8799103 _d8799103 |